Standard combination versus alternating chemotherapy in small cell lung cancer
- 1 August 1999
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 25 (2) , 105-113
- https://doi.org/10.1016/s0169-5002(99)00050-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Factors influencing use of alternating chemotherapy and radiation schedules in small cell lung cancerLung Cancer, 1994
- Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung CancerNew England Journal of Medicine, 1993
- Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVDNew England Journal of Medicine, 1992
- Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1991
- Alternating or sequential chemotherapy in small cell lung cancer?Lung Cancer, 1989
- Chemotherapy of Small Cell Lung CancerChest, 1989
- Cyclic alternating 'non-cross resistant' chemotherapy in the management of small cell anaplastic carcinoma of the lungCancer Treatment Reviews, 1984
- Evaluation of alternating chemotherapy and sites and extent of disease in extensive small cell lung cancerCancer, 1981
- Chemotherapy of small cell carcinoma of the lung: Comparison of a cyclic alternative combination with simultaneous combinations of four and seven agentsEuropean Journal of Cancer and Clinical Oncology, 1981
- Combination chemotherapy of advanced lung cancer.A randomized trialCancer, 1976